November 17, 2022
1 min read
Bamforth RJ, et al. FR-PO542. Presented at: ASN Kidney Week; November 3-6, 2022; Orlando (hybrid meeting).
Presentation: Bamforth does not disclose relevant financial information.
ORLANDO — Using a real-time potassium monitoring device in hemodialysis patients could save more money than conventional care and increase quality of life, according to a presenter at ASN Kidney Week.
In addition, the researchers found that the device prevents hyperkalemic events among patients on hemodialysis.
Ryan J. Bamforth
Ryan J. Bamforth, MS, MSc, and colleagues compared the cost and quality of life associated with the use of a real-time potassium monitoring device in patients undergoing hemodialysis and conventional care. The investigators developed an analytic microsimulation model from the perspective of a United States health care payer with the intention of conducting a cost-performance analysis.
The analysis focused on the monthly cost per patient and the incremental cost-effectiveness ratio comparing the two interventions, including costs related to hyperkalemic events and dating Researchers derived estimates for patients on hemodialysis from a systematic review and meta-analysis. Additionally, the researchers applied a 25% reduction in hyperkalemic events to the intervention condition as an estimate of effectiveness.
Analyzes revealed that the monthly out-of-pocket cost per patient in the case scenario was $689.56. In addition, the real-time battery monitoring device provided 0.04 more quality-adjusted life-years. The researchers reported that adjusted cost-effectiveness estimates between reductions in hyperkalemic events ranged between 10% and 50%, with monthly costs ranging from $265.36 to $1,387.90.
“Basically, the bottom line is that if we implement this potassium monitoring device, if 10% and 15% of all hyperkalemic events are avoided in this population, the cost of this situation will be lower. for the system and the individuals. to have more years of quality assurance,” Bamforth told Healio.